Netazepide, a gastrin/CCK2 receptor antagonist, can eradicate gastric neuroendocrine tumours in patients with autoimmune chronic atrophic gastritis

Category Primary study
ConferenceNeuroendocrinology
Year 2016
This article has no abstract
Epistemonikos ID: 71b162e8db5e9060799731ed65a08c11c39d2fa8
First added on: Apr 29, 2026